The Harvard Drug Group, LLC recalls
Every recall we track for The Harvard Drug Group, LLC — 10 in all, from 2014–2026 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls per year, by danger level
Recalls from The Harvard Drug Group, LLC peaked in 2025 (4); 8 since 2017.
All FDA recall records for The Harvard Drug Group, LLC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 2 | 2 | 4 |
| 2026 (to date) | 0 | 0 | 4 | 0 | 4 |
The Harvard Drug Group, LLC recalls before 2017
Recalls on record by year.
Most common reasons for The Harvard Drug Group, LLC recalls
What to do if you have a recalled The Harvard Drug Group, LLC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All The Harvard Drug Group, LLC recalls
8 shown- Lower riskDrug
The Harvard Drug Group LLC recalls Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and
Harvard Drug Group recalls methylergonovine maleate tablets (0.2 mg) with subpotent drug risk. Affected lots expire 09/2026 to 08/2027. Consumers should contact the manufacturer for details.
The Harvard Drug GroupJun 16, 2026 - Lower riskDrug
The Harvard Drug Group LLC recalls Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only,
Harvard Drug Group recalls Omega-3 Acid Ethyl Esters capsules due to failed stability testing for loss on drying. This may affect product quality but does not pose immediate safety risks.
Harvard Drug GroupApr 9, 2026 - Lower riskDrug
The Harvard Drug Group LLC recalls Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and
Harvard Drug Group recalls 7mg Memantine Hydrochloride Extended-Release capsules due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Harvard Drug GroupMar 24, 2026 - Lower riskDrug
The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by:
Harvard Drug Group recalls 50-tablet Midodrine hydrochloride tablets with inadequate blister packaging sealing. This could lead to tablet exposure to moisture or contaminants.
Harvard Drug GroupFeb 17, 2026 - UnratedDrug
The Harvard Drug Group LLC recalls Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major
Harvard Drug Group recalls 100mg Gabapentin Capsules (10 per blister) with potential impurities from stability testing. Affected lots expire 02/2026 to 01/2027. No specific remedy provided in recall notice.
Harvard Drug GroupOct 10, 2025 - Lower riskDrug
The Harvard Drug Group LLC recalls Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by:
Harvard Drug Group recalls 100mg Gabapentin Capsules (100-count blister packs) because the packaging may not seal properly. This could lead to contamination or exposure to air. Consumers should contact the manufacturer for details.
Harvard Drug GroupJun 19, 2025 - Stop using nowDrug
The Harvard Drug Group, LLC recalls OXYCODONE HCl C-II Tablets, 5 mg USP, 100-count blister cards, Rx only, Manufactured by Nesher Pharmaceuticals USA
The Harvard Drug Group is recalling specific lots of 5 mg oxycodone tablets because some blister cards may contain two pills instead of one, posing a serious overdose risk.
The Harvard Drug GroupJun 10, 2015 - Lower riskFood
The Harvard Drug Group, LLC recalls Thera Tablets with Beta Carotene Dietary Supplement
The Harvard Drug Group recalls Thera Tablets with Beta Carotene (Lot M-00953) due to missing labeling information on blister packets.
TheraDec 31, 2014
The Harvard Drug Group, LLC recall questions
How many recalls has The Harvard Drug Group, LLC had?
10 recalls from The Harvard Drug Group, LLC are on record with U.S. safety agencies, from 2014–2026 (9 drug, 1 food).
What is the most recent The Harvard Drug Group, LLC recall?
The Harvard Drug Group LLC recalls Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and, dated Jun 16, 2026. Every The Harvard Drug Group, LLC recall is listed on this page, newest first.
Why are The Harvard Drug Group, LLC products recalled?
The most common reasons on record: Defective container; blister packaging inadequately sealed. (2).
What should I do if I have a recalled The Harvard Drug Group, LLC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new The Harvard Drug Group, LLC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.